FDA Inspection 1219106 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on Aug 24, 2023 in Fayetteville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 24, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fayetteville, NC (United States)